Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease

Overview of attention for article published in Thrombosis Journal, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 363)
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 25 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Soliris Treatment Resolved aHUS in 2 Patients with Inflammatory Bowel Disease, Study Reports

Medical Health News, 10 Oct 2019

Treatment with Soliris (eculizumab) led to successful resolution of atypical hemolytic uremic syndrome (aHUS) that was…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.